Pierre Fabre Médicament Portugal, Ltd.

Poland

All drugs from this manufacturer

  • TARDYFERON

    The medicine is used to treat iron deficiency anemia and to prevent iron deficiency in pregnant women (when dietary iron intake is insufficient).

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg

    ATC: B03AA07

  • It is used in the treatment of iron deficiency anemia and in the prevention of iron deficiency in pregnant women whose diet is insufficient. It is indicated for adults and children over 10 years of age.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg

    ATC: B03AA07

  • The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg
    folic acid 0.35 mg

    ATC: B03AD03

  • The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg
    folic acid 0.35 mg

    ATC: B03AD03

  • The medicine is used to prevent and treat iron and folic acid deficiencies in pregnant women.

    Dosage form: tablets, prolonged release

    Active substance Dosage
    ferrous sulfate 80 mg
    folic acid 0.35 mg

    ATC: B03AD03